ClearPoint Neuro (CLPT) Operating Leases (2019 - 2026)

ClearPoint Neuro has disclosed Operating Leases across 8 years of filings, most recently posting $13.7 million for Q1 2026.

• Operating Leases for Q1 2026 came in at $13.7 million, up 379.37% year-over-year; the trailing twelve-month figure through Mar 2026 was $13.7 million (up 379.37% YoY), and the FY2025 annual result was $8.5 million, up 181.0% from the prior year.
• Operating Leases came in at $13.7 million for Q1 2026 at ClearPoint Neuro, up from $8.5 million in the prior quarter.
• In the past five years, Operating Leases ranged from a high of $13.7 million in Q1 2026 to a low of $1.4 million in Q1 2023.
• The 5-year median for Operating Leases is $3.3 million (2024), against an average of $4.1 million.
• Across the five-year window, Operating Leases retreated 25.88% in 2022 and surged 379.37% in 2026, its largest moves.
• ClearPoint Neuro's Operating Leases stood at $1.5 million in 2022, then surged by 132.9% to $3.6 million in 2023, then decreased by 15.61% to $3.0 million in 2024, then surged by 181.0% to $8.5 million in 2025, then surged by 62.04% to $13.7 million in 2026.
• The last three Operating Leases figures came in at $13.7 million (Q1 2026), $8.5 million (Q4 2025), and $6.2 million (Q3 2025), per Business Quant data.